Strainprint™ Technologies Ltd. (“Strainprint”) Welcomes Three Leading Cannabinoid Physicians to its Board

Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman
Join Strainprint’s World-Class Medical Advisory Board

TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely with its medical advisors to support patients, enhance research and to advance the scientific understanding of cannabinoid therapy. With over 400,000 medical records and almost 7 million data points, and growing, Strainprint is the most trusted source for strain efficacy and patient use data. Dr. MacCallum and Dr. Schecter will jointly lead Strainprint’s Medical Advisory Board as Co-chairs and Dr. Elterman will focus on specific cannabinoid studies through the University Health Network.

Dr. Caroline MacCallum graduated from UBC Internal Medicine Residency in 2013. She practiced complex pain in a number of clinics and hospitals in Vancouver including, Vancouver General Hospital Pain & Addiction Service, Change Pain clinic and BC Women’s Complex Chronic Disease Program. She is also clinical instructor in the UBC Department of Medicine, guest lecturer and preceptor for UBC Faculty of Pharmaceutical Sciences Program and the Medical Director for Greenleaf Medical Clinic. Dr. MacCallum has created online cannabis courses, CMEs, and preceptorships for physicians. She works with national committees to create cannabis guidelines and safe prescribing practices, as well as writing cannabis policy for hospitals and drug benefit plan coverage. She is qualified as a medical cannabis expert and has testified in arbitration. Her research interests include: cannabis for the treatment of complex medical conditions; cannabis for opioid and polypharmacy reduction; as well as cannabis and impairment.

Dr. Danial Schecter is co-founder of the Cannabinoid Medical Clinic (CMClinic) and a practicing family physician. After working alongside some of Canada’s leading researchers in the field of medical marijuana, Dr. Schecter developed a strong interest in the therapeutic use of cannabinoids. As a recognized medical expert in the field of prescription cannabinoids and medical marijuana, Dr. Schecter has spoken at over 100 conferences both nationally and internationally and has developed educational programs on this subject. Dr. Schecter sits on a variety of cannabis advisory boards and consults internationally to key industry stakeholders in Australia, Latin America and Europe. In addition to cannabinoid medicine, Dr. Schecter’s clinical interests include delivering a high standard of care to at-risk elderly and palliative care patients, prompting him to establish his own house-calls service in Georgian Bay, ON. Dr. Schecter completed a fellowship in Hospital Medicine and is an active hospitalist at the Royal Victoria Regional Health Centre in Barrie, ON.

Dr. Dean S. Elterman completed his medical degree followed by residency in urologic surgery at the University of Toronto. He has a Masters in Clinical Epidemiology and Health Services Research from Cornell and completed a 2-year fellowship at Memorial Sloan-Kettering Cancer Center and New York Presbyterian Hospital/Weill Cornell Medical College in New York City. Dr. Elterman is an attending surgeon at UHN (University Health Network) and an Assistant Urology Professor in the Department of Surgery at University of Toronto. He is the Medical Director of the Prostate Cancer Rehabilitation Clinic at Princess Margaret Hospital Cancer Centre and a clinician Investigator in the Krembil Research Institute at Toronto Western hospital. Dr. Elterman is chair of the medical advisory board for Molecular Science Corp. and has a particular interest in the study of cannabis and cannabinoid therapy.

“All three of our new medical advisors are leaders in their respective fields and devoted to advancing cannabinoid research and therapy. We are so proud to be working with these great physicians who will help us to shape both the medical and recreational cannabis industries with real-world, real-time, medical-grade data,” said Strainprint CEO, Andrew Muroff.

Read More about Strainprint Advisors

About Strainprint™:
Founded in Toronto in 2016, Strainprint™ Technologies Ltd. is the leading demand-side cannabis data and analytics company, featuring medically validated cannabis consumption and efficacy data on lab-verified strains. StrainprintTM data supports global cannabis research and provides advanced, real-time business intelligence and treatment guidance to producers, retailers, medical practitioners, pharma, government and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly integrated with most electronic medical records (EMR), seed2sale and Ecomm software systems. Strainprint Analytics is accessed by customer subscription. The Strainprint App is free to patients and can be downloaded for both iOS and Android devices. www.strainprintanalytics.com. facebook, twitter, linkedin

For further information: Media Contact: Jessica Moran, Strainprint™ Technologies Ltd., Jessica.moran@strainprint.ca, 519-494-5379

Strainprint Technologies Ltd. Is Pleased to Welcome Ashleigh Brown as Community Manager & Patient Liaison As The Team Continues To Expand

Strainprint is proud to announce our latest member of the Strainprint team, Ashleigh Brown. Ashleigh has come on board to be Strainprint’s Community Manager and Patient Liaison.

Ashleigh’s own journey as a medical cannabis patient as well as the Founder of SheCann: Legal Medical Cannabis Empowering Canadian Women gives her the unique opportunity to deepen the connections she has with fellow patients, as well as channel her empathy, love of learning and all things data into helping patients use cannabis better, and mindfully medicate.

Q: When and why did you start using medical cannabis?

A: I received my medical cannabis prescription in August 2016. I started using medical cannabis as a last resort, really. In 2009, I began having seizures, and by 2016 I had exhausted all of my medical options. At my worst point, I was having 150-180 events per month. I had the cognitive functioning of a 70-year-old with senile dementia. Using medical cannabis has changed all of that. I still have seizures, but they no longer number in the hundreds. I have around 12-15 per month now. I am able to care for my daughters, attend their school events, and I am able to work again.

Q: What are you passionate about?

A: I start every morning with the same few words to myself: ‘let me be of service to people in the ways they need me’. I am passionate about helping people, and what I have learned is that at the core of so much of our human experience is a need to just feel seen. I am passionate about serving people, and I am humbled to be able to do so during some of their darkest and most challenging times.

Q: What do you like to do in your spare time?

A: I have always been a voracious reader. My nightstand is never without a stack of novels and works of non-fiction, and my Kobo goes with me everywhere. Words are some of my favourite things. I also love to spend time outside with my partner and my two daughters: last year my partner and I purchased a tandem bike, so we could hit the open road together…and embarrass the kids!

Q: What has been a defining moment for you thus far on your medical cannabis journey?

A: I began using medical cannabis at the suggestion of my best friend. Frankly, my first reaction was a bit dismissive. I had used it recreationally and it hadn’t helped. She told me to ‘forget everything I thought I knew about marijuana’. It was the best advice anyone could have given me, and it is the same advice I now give to others every day. Making the mental shift from ‘recreation’ to ‘medication’ is something that happened as a result of that support.

Q: What is the more unexpected thing you’ve encountered along your journey?

A: The biggest surprise in all of this, especially since I began my journey as an advocate, is how many people have these amazing stories of recovery, healing and hope. I am happy to say that my story is not unique: it is one of thousands of accounts of how using medical cannabis has improved and changed lives.

Q: What would you say to your younger/less experienced self?

A: “It gets better.” I love being in my thirties, because enough time has passed that I understand that life happens, but we can and do grow through the challenges. If my younger self was open to listening, I would remind her, and really anyone else, that you have survived 100% of your days. That’s a perfect record.

Q: If you weren’t doing this and could do ANYTHING what would you be doing?

A: I am so happy with my life right now. This all feels like a perfect fit, for me, my family, and my purpose. I can’t imagine doing anything else. But if I had to choose? I think I would work at Best Friends Animal Sanctuary in Utah. I could scoop poop there for eternity. It is not only one of the most beautiful places on earth, the work that the staff and volunteers do is monumental.

Q: Talk about your involvement with SheCann and why it is such an important forum/platform

A: When I founded SheCann in June of 2017, myself and a handful of other female patients had no idea how it would all unfold. We started the community in order to have a safe space to ask questions, and access resources and support around medical cannabis, without the stigma.

SheCann is a special Canadian Facebook community. It defies the stereotypes of most social media groups. There is no negativity, or hostility. We welcome vulnerability, curiosity, and compassion. We are patient focused, but we also welcome and encourage members of the medical cannabis industry to join us; including Licensed Producers, and clinics. We work closely with groups like CFAMM on the issues that matter to us as patients.

Our members are committed to advocating for themselves and others, and as legalization approaches, we want to speak up on issues that affect our access to medication.

We are stronger together. It is amazing and so empowering to learn more about our medicine by sharing our experiences. There are no stupid questions, and there are no invalid perspectives.

Q: What awards has SheCann/Yourself received?

A: The team and I were blown away to receive 3rd place in the Best Social Media Account-Facebook category at the Canadian Cannabis Awards in November.

Q: What does your daily life look like, beyond work?

A: We have a really diverse and amazing blended family. My daughters are 9 and (almost) 13, I have three brilliant, compassionate and wonderful adult step kids who have equally wonderful partners and spouses, and we have two granddaughters who never fail to keep us all smiling.